List of works - Matthias D'Huyvetter

(18)F-nanobody for PET imaging of HER2 overexpressing tumors.

scientific article published on 23 January 2016

131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

scientific article published on 27 July 2017

Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer

scientific article published on 5 March 2018

Gallium-68-labelled NOTA-oligonucleotides: an optimized method for their preparation

scientific article published on 29 December 2015

Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

scientific article published on 03 July 2019

Molecular imaging using Nanobodies: a case study.

scientific article published in January 2012

PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments

scientific article published on 11 June 2015

Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

scientific article published on 21 April 2020

Reshaping nanobodies for affinity purification on protein a

scientific article published on 27 January 2020

SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis

scientific article published on 27 February 2013

Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology

scientific article published on 15 March 2018

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

scientific article published on 01 January 2012

Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours

scientific article published on 14 November 2019

Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

scientific article published on 15 October 2019

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.

scientific article published on 04 May 2016

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy

scientific article published in January 2022

Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma.

scientific article published on 20 October 2017

Theranostics in immuno-oncology using nanobody derivatives